CurrentUnitedHealthcarePolicy CS015OH.G

Cardiovascular Disease Risk Tests Oh Cs

State-specific UnitedHealthcare medical policy for Ohio addressing use and coverage stance on cardiovascular disease risk tests including arterial compliance/waveform analysis, endothelial function assessment (PAT, brachial artery ultrasound), carotid intima-media thickness (CIMT), advanced lipoprotein analysis, multiprotein biomarker panels, Lp(a), and Lp-PLA2; provides evidence review and lists applicable procedure codes for reference.

Policy Summary

PayerUnitedHealthcare

PolicyCardiovascular Disease Risk Tests Oh Cs

Policy CodePolicy CS015OH.G

Change TypeRevised (Description of Services, Clinical Evidence, References)

Effective DateJune 1, 2026

Next Review Date

Key ActionOrder Lp(a) and apoB selectively per guideline indications and document clinical rationale in the record.

SourceLink

POLICY UPDATE CHANGES

Updated Description of Services, Clinical Evidence, and References sections to reflect the most current information.

5+Specific multiprotein panels listed as unproven

3Imaging / physiologic modalities designated unproven

15Procedure codes listed for reference

observational-heavyPredominant study design